quit smoking Pfizer's smoking cessation drug fails to meet primary endpoint in phase 4 study March 27, 2018 jhgreene Pfizer’s smoking cessation drug fails to meet primary endpoint in phase 4 study Pharmaceutical Business Review Full coverage